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MISONIDAZOLE (MISO) has now reached
Phase III prospective randomized clinical
trials as an adjunct to radiotherapy. It
was introduced in the first instance as a
radiosensitizer of hypoxic cells (Asquith,
et al., 1974) but laboratory investigations
soon showed that MISO is also specifically
cytotoxic for hypoxic cells after prolonged
exposure (Sutherland, 1974; Hall& Roizin-
Towle, 1975) and that the sensitizing effec-
tivenessofagiven concentrationofthedrug
isenhanced by prolonged incubation ofthe
hypoxic cells with the drug before irradia-
tion (Hall & Biaglow, 1977; Wong et al.,
1978). While the mechanism for this pre-
incubation effect is not entirely clear, there
is good evidence that it is due in part to
the depletion of non-protein sulphhydryl
compounds in the cell by the prolonged
exposure to MISO (Biaglow et al., 1981;
Hall et al., 1982).
When MISO is used in clinical radio-
therapy, it is common practice to irradiate
4 h after oral administration, when drug
concentration has reached a maximum
in the tumour. If irradiation were further
delayed, 2 processes would operate simul-
taneously. First, the drug concentration
would decrease exponentially due to drug
excretion. Second, the effective radio-
sensitizing effectiveness of the remaining
drug would increase due to the pre-
incubation or prolonged storage. Whether
the resultant effect of combining these
two processes would be an overall increase
or decrease ofradiosensitizing effectiveness
with increased time between drug admin-
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istration and irradiation must depend
upon the half-life ofthe drug, the dose and
time relationships for the pre-incubation
effect, and the shape of the curve relating
enhancement ratio (ER) to concentration
of MISO. It is not possible to predict the
outcome from previously available data,
and the present paper describes experi-
ments in which cells, cultured in vitro,
were used to simulate the in vivo situation
and to investigate the effect of prolonged
incubation before irradiation for a range
ofsimulated drug half-lives.
Chinese hamster (V79) cells were used
for these experiments, grown in FIO
culture medium supplemented with 10%
fetal bovine serum, penicillin and strepto-
mycin. Cells were irradiated in suspension
in glass vessels specially fabricated based
on the design of Chapman et al. (1977).
Cells were kept in suspension at a con-
centration of 2 x 106/ml by means of a
magnetic stirrer, maintained at 37 5°C by
immersion of the glass vessel in a water
bath, and made hypoxic by passing high-
purity N2 ( < 10 pt/106 of 02) plus 5%
CO2 over the surface of the stirred cell
suspension for a period of 1 h. Meanwhile
the MISO, dissolved in complete growth
medium, was degassed in a separate glass
vessel and added to the cells to achieve a
final concentration of 1 mm when both
cells and drug were hypoxic. Parallel
cultures were gassed with air plus CO2 and
handled in the same way. One vessel con-
taining cells was irradiated 5 min after the
addition of the MISO in order to assessE. ,J. HALL AN1)DM. ASrl'ORi
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the immediate radiosensitizing effective-
ness of the full concentration of I mm;
this interval is sufficient for the drug to
equilibrate with the cells and produce an
ER of b17. The other 6 cell suspensions
were irradiated 4' h later, and in the
intervening period hypoxic complete
growth medium was added hourly to
simulate the decay of the drug concentra-
tion, which in vivo approximates to an
exponential. This technique has been used
previously by Stratford & Adams (1978).
The effective half-lives simulated were 90
min, 4, 8, 12 and 16 h. An additional cell
suspension was not diluted at all to assess
the full impact ofthe pre-incubation effect
with no decay of drug concentration. Fig.
I illustrates the residual concentration of
MISO at the time of irradiation, corres-
ponding to various simulated drug half-
lives.
The source of radiation was a Siemens
Stabilapan X-ray machine, operated at
300 kVp, 12 mA, with added filtration of
0 2 mm Cu, at a treatment distance of
25 cm; the dose rate was computed as
6-3 Gy/min. Graded doses of X-rays were
delivered to each cell suspension, and
aliquots removed after various doses
through a long side-arm on the glass
vessel, without disturbing the level of
hypoxia. These cell samples were seeded
into culture flasks containing fresh growth
medium, to assay for colonv formation.
Fig. 2 shows data from a large self-
contained experiment in which hypoxic
cells were irradiated immediately after
the addition of 1 mai MISO, or 41 h later,
when the drug administration had de-
creased exponentially with a range of
effective half-lives. The effect ofprolonged
pre-incubation with MISO on the radio-
sensitizing effectiveness has previously
been expressed in terms of the Extra
Enhancement Ratio (EER) defined to be
the ratio of doses delivered after 41 h and
to that immediately required to produce
an equal biological effect. From the data
of Fig. 2, EER values were calculated for
a surviving fraction of 041 and are plotted
in Fig. 3. The results indicate that, when
drug concentration decays exponentially
with a 4h half-life, the same radiosensitiza-
tion is obtained whether the radiation is
delivered immediately after the addition
of the drug or delayed for 41 h. The reduc-
tion of radiosensitization due to the
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Fie:. 2. Survival data for Cihinese lhamster
V79 cells exposed to graded doses ofX-rays
at various times after th-ie administration of
MNIISO at an initial concentration of 1 mii.
Decay of the (irug with various half-lives
was simulate(l by the adldition of extra
growtlh medium. X-raye(d at 41 h, witl
variouis half lives (Ti/2): 0, 90 mm; *,
4h; 0,8 I; *, 121h; *, 16 h; and oo,-.
Also shown are results with 41 h hypoxia
alone followe(d by X-rays (O) an(d X-rays
immediately after adding MISO (A),
w%hich is equivalent in effect, to N-rays 41 h
later with a T,12 of 4 h.
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FIG. 3.-Extra Enhancement Radio (EER)
as a function of simulated drug half-life.
The EER is defined to be the ratio ofX-ray
dose delivered immediately after the addi-
tion of 1mM MISO to the dose required 4i h
later, to produce equal biological effect.
lowered drug concentration is therefore
balanced precisely by the increase due to
the pre-incubation. For a 90min drug
half-life, mimicking that of the mouse,
delaying irradiation for 41 h reduces the
net radiosensitization, because the rapid
drug removal cannot be balanced by the
pre-incubation effect. On the other hand,
for half-lives of 8, 12 or 16 h, spanning the
range of values reported for MISO in the
human, delaying irradiation by 5 h results
in increased radiosensitization, because
the benefit of prolonged pre-incubation
more than offsets the slower drug decay.
The results described above suggest
that, in the clinical use of MISO in the
human, a benefit may accrue from allow-
ing a longer time between administration
of the sensitizer and irradiation than is
commonly used at present. Due to tech-
nical limitations of in vitro experiments,
the drug concentration chosen was at
least double that achievable in the clinic,
but this should not alter the principle
involved. Several clinical trials with MISO
that show early promise, especially those
of the European cooperative group, in-
volve hyper-fractionation, so that on the
days that MISO is administered, two
X-ray dose fractions are delivered, the
first 4 h after the drug and the second 4 h
later again. It may be that the second dose
fraction is particularly effective in steril-
izing hypoxic cells, since advantage is
taken of the pre-incubation effect.
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